Basilea Pharmaceutica AG (SWX:BSLN)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	669	672	501	423	546	485
Market Cap Growth	37.40%	34.10%	18.52%	-22.52%	12.62%	-15.59%
Enterprise Value	598	641	551	505	636	551
Last Close Price	54.40	54.70	41.35	35.30	45.80	40.92
PE Ratio	17.31	16.70	6.46	40.47	44.94	-
Forward PE	12.64	13.26	10.63	15.17	98.35	-
PS Ratio	2.88	2.89	2.40	2.68	3.69	3.27
PB Ratio	5.23	5.25	6.19	-42.28	-26.35	-8.27
P/TBV Ratio	5.24	5.27	6.22	-	-	-
P/FCF Ratio	11.24	11.30	6.90	31.48	139.32	-
P/OCF Ratio	10.77	10.83	6.74	29.69	77.36	-
EV/Sales Ratio	2.57	2.76	2.64	3.20	4.31	3.72
EV/EBITDA Ratio	10.63	11.85	8.68	21.78	29.31	154.82
EV/EBIT Ratio	11.45	12.26	8.93	23.05	30.58	183.33
EV/FCF Ratio	10.06	10.77	7.58	37.59	162.43	-
Debt / Equity Ratio	0.70	0.70	1.38	-12.86	-9.03	-3.74
Debt / EBITDA Ratio	1.59	1.59	1.71	5.05	7.76	41.61
Debt / FCF Ratio	1.50	1.50	1.54	9.57	47.76	-
Net Debt / Equity Ratio	-0.55	-0.55	-0.11	-6.86	-4.95	-1.20
Net Debt / EBITDA Ratio	-1.30	-1.30	-0.14	2.96	4.72	19.72
Net Debt / FCF Ratio	-1.19	-1.19	-0.12	5.11	26.16	-2.15
Asset Turnover	0.86	0.86	0.97	0.80	0.63	0.62
Inventory Turnover	5.46	5.46	3.99	4.13	4.18	5.33
Quick Ratio	4.53	4.53	3.93	2.48	1.96	1.22
Current Ratio	5.12	5.12	4.85	3.20	2.34	1.38
Return on Equity (ROE)	38.52%	38.52%	218.58%	-	-	-
Return on Assets (ROA)	12.10%	12.10%	17.89%	6.95%	5.56%	0.79%
Return on Invested Capital (ROIC)	79.90%	70.88%	94.46%	31.17%	44.56%	-
Return on Capital Employed (ROCE)	22.40%	22.40%	29.10%	17.40%	14.30%	4.10%
Earnings Yield	6.02%	5.99%	15.48%	2.47%	2.23%	-1.41%
FCF Yield	8.89%	8.85%	14.50%	3.18%	0.72%	-6.73%
Buyback Yield / Dilution	1.23%	1.23%	-14.10%	-1.67%	-2.24%	-13.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.